CompaniesKaro Bio

Karo Bio

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

678

By Phase

PHASE3: 1PHASE2: 3

By Status

COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
Today
NCT01410383
Hover over trial bars to see details

Recent Trials

NCT01410383Lead Sponsor
Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care
PHASE3Terminated
236 participants
Started: Oct 31, 2011 · Completed: Oct 31, 2014
NCT00677248Lead Sponsor
LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe
PHASE2Completed
120 participants
Started: Apr 30, 2008 · Completed: Oct 31, 2008
NCT00593047Lead Sponsor
LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin
PHASE2Completed
180 participants
Started: Nov 30, 2007 · Completed: Sep 30, 2008
NCT00776321Lead Sponsor
Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia
PHASE2Completed
142 participants
Started: Sep 30, 2006 · Completed: Oct 31, 2007